“…Molecular modeling studies showed that pyrazole analogs interact with the cyclooxygenase-2 (COX-2) active site by classical hydrogen bonding, π-π interaction, and cation-π interaction which increases the residence of the ligand in the active site, consequently augmenting the anti-inflammatory activity of the compounds. 11 Anti-bacterial activity was also tested by Ragavan et al, 12 who have synthesized a group of 1,5-diaryl pyrazoles by altering the active part (amide linkage) and tested the products for anti-bacterial activity against E. coli (American Type Culture Collection [ATTC] -25922), S. aureus (ATTC-25923), Pseudomonas aeruginosa (ATTC-27853), and Klebsiella pneumonia. As anti-cancer agents, pyrazoles have potent anti-angiogenic activity, and inhibit the growth of human breast (MCF-7) and cervical (Hela) carcinoma cells in vitro.…”